Abbott Laboratories (ABT) Return on Capital Employed Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,683.00 |
| Dec 31, 2025 | -1,059.00 |
| Sep 30, 2025 | 374.00 |
| Jun 30, 2025 | 378.00 |
| Mar 31, 2025 | -764.00 |
| Dec 31, 2024 | -671.00 |
| Sep 30, 2024 | 396.00 |
| Jun 30, 2024 | 403.00 |
| Mar 31, 2024 | 432.00 |
| Dec 31, 2023 | 497.00 |
| Sep 30, 2023 | 458.00 |
| Jun 30, 2023 | 555.00 |
| Mar 31, 2023 | 2,549.00 |
| Dec 31, 2022 | 3,502.00 |
| Sep 30, 2022 | 1,302.00 |
| Jun 30, 2022 | 1,370.00 |
| Mar 31, 2022 | 2,887.00 |
| Dec 31, 2021 | 2,305.00 |
| Sep 30, 2021 | 424.00 |
| Jun 30, 2021 | 306.00 |
| Mar 31, 2021 | 1,776.00 |
| Dec 31, 2020 | 1,339.00 |
| Sep 30, 2020 | -108.00 |
| Jun 30, 2020 | -134.00 |
| Mar 31, 2020 | 943.00 |
| Dec 31, 2019 | 914.00 |
| Sep 30, 2019 | -26.00 |
| Jun 30, 2019 | 21.00 |
| Mar 31, 2019 | -3.00 |
| Dec 31, 2018 | -84.00 |
| Sep 30, 2018 | 22.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 45.00 |
| Dec 31, 2017 | -22.00 |
| Sep 30, 2017 | 409.00 |
| Jun 30, 2017 | 368.00 |
| Mar 31, 2017 | 222.00 |
| Dec 31, 2016 | 401.00 |
| Sep 30, 2016 | -238.00 |
| Jun 30, 2016 | -400.00 |
| Mar 31, 2016 | -481.00 |
| Dec 31, 2015 | -572.00 |
| Sep 30, 2015 | -695.00 |
| Dec 31, 2014 | -985.00 |
| Sep 30, 2014 | -1,012.00 |
| Jun 30, 2014 | -1,209.00 |